Follow
Dr. George Priya Doss C
Title
Cited by
Cited by
Year
Therapeutic miRNA and siRNA: moving from bench to clinic as next generation medicine
C Chakraborty, AR Sharma, G Sharma, CGP Doss, SS Lee
Molecular Therapy-Nucleic Acids 8, 132-143, 2017
7472017
Influence of miRNA in insulin signaling pathway and insulin resistance: micro‐molecules with a major role in type‐2 diabetes
C Chakraborty, CGP Doss, S Bandyopadhyay, G Agoramoorthy
Wiley Interdisciplinary Reviews: RNA 5 (5), 697-712, 2014
2412014
Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetes
G Sharma, AR Sharma, JS Nam, GPC Doss, SS Lee, C Chakraborty
Journal of nanobiotechnology 13 (1), 1-13, 2015
1742015
The rise and impact of COVID-19 in India
SU Kumar, DT Kumar, BP Christopher, CGP Doss
Frontiers in medicine 7, 250, 2020
1622020
Molecular dynamics: new frontier in personalized medicine
P Sneha, CGP Doss
Advances in protein chemistry and structural biology 102, 181-224, 2016
1472016
Identification and in silico analysis of functional SNPs of the BRCA1 gene
R Rajasekaran, C Sudandiradoss, CGP Doss, R Sethumadhavan
Genomics 90 (4), 447-452, 2007
1032007
Analysis of differentially expressed genes and molecular pathways in familial hypercholesterolemia involved in atherosclerosis: a systematic and bioinformatics approach
S Udhaya Kumar, D Thirumal Kumar, R Bithia, S Sankar, R Magesh, ...
Frontiers in Genetics 11, 734, 2020
872020
BSA nanoparticle loaded atorvastatin calcium—a new facet for an old drug
AR Sripriyalakshmi. S, Anjali. C. H, George Priya Doss. C, Rajith B
PLOS ONE 9 (e86317), 2014
782014
Screening of mutations affecting protein stability and dynamics of FGFR1—A simulation analysis
CGP Doss, B Rajith, N Garwasis, PR Mathew, AS Raju, K Apoorva, ...
Applied & translational genomics 1, 37-43, 2012
752012
Integrative bioinformatics approaches to map potential novel genes and pathways involved in ovarian cancer
SU Kumar, DT Kumar, R Siva, CGP Doss, H Zayed
Frontiers in bioengineering and biotechnology 7, 391, 2019
722019
TNF/TNFR: drug target for autoimmune diseases and immune-mediated inflammatory diseases.
GP Doss, G Agoramoorthy, C Chakraborty
Frontiers in bioscience (Landmark edition) 19 (7), 1028-1040, 2014
632014
DNA barcoding to map the microbial communities: current advances and future directions
C Chakraborty, CGP Doss, BC Patra, S Bandyopadhyay
Applied Microbiology and Biotechnology 98, 3425-3436, 2014
632014
Investigation on the role of nsSNPs in HNPCC genes–a bioinformatics approach
C Doss, R Sethumadhavan
Journal of biomedical science 16 (1), 1-14, 2009
602009
Genetic epidemiology of glucose-6-phosphate dehydrogenase deficiency in the Arab world
CGP Doss, DR Alasmar, RI Bux, P Sneha, FD Bakhsh, I Al-Azwani, ...
Scientific reports 6 (1), 37284, 2016
592016
Extrapolating the effect of deleterious nsSNPs in the binding adaptability of flavopiridol with CDK7 protein: a molecular dynamics approach
C George Priya Doss, N Nagasundaram, C Chakraborty, L Chen, H Zhu
Human genomics 7 (1), 1-15, 2013
582013
Unraveling the inhibition mechanism of cyanidin-3-sophoroside on polyphenol oxidase and its effect on enzymatic browning of apples
H Hemachandran, A Anantharaman, S Mohan, G Mohan, DT Kumar, ...
Food Chemistry 227, 102-110, 2017
572017
miRNAs in insulin resistance and diabetes-associated pancreatic cancer: the ‘minute and miracle’molecule moving as a monitor in the ‘genomic galaxy’
C Chakraborty, D Priya, S Bandyopadhyay
Current drug targets 14 (10), 1110-1117, 2013
572013
The role of photosynthesis related pigments in light harvesting, photoprotection and enhancement of photosynthetic yield in planta
AJ Simkin, L Kapoor, CGP Doss, TA Hofmann, T Lawson, S Ramamoorthy
Photosynthesis Research 152 (1), 23-42, 2022
562022
Dysregulation of signaling pathways due to differentially expressed genes from the B-cell transcriptomes of systemic lupus erythematosus patients–a bioinformatics approach
S Udhaya Kumar, D Thirumal Kumar, R Siva, C George Priya Doss, ...
Frontiers in Bioengineering and Biotechnology 8, 276, 2020
562020
Evolution-and structure-based computational strategy reveals the impact of deleterious missense mutations on MODY 2 (maturity-onset diabetes of the young, type 2)
DCP George, C Chakraborty, SAS Haneef, N NagaSundaram, L Chen, ...
Theranostics 4 (4), 366, 2014
562014
The system can't perform the operation now. Try again later.
Articles 1–20